Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CARBOPROST TROMETHAMINE INJECTION, USP DIN 02553856

Status: Approved
Holder: DR REDDY'S LABORATORIES LTD
Molecule: CARBOPROST (CARBOPROST TROMETHAMINE)

Health Canada record

Active ingredient(s)CARBOPROST (CARBOPROST TROMETHAMINE) 250 MCG
Dosage formSolution
RouteIntramuscular
SchedulePRESCRIPTION
ClassHuman
ATCG02AD04 CARBOPROST
Original market date
Current status date11-Dec-2024
SourceHealth Canada DPD

Establishment licence of the holder

Dr Reddy's Laboratories (UK) Limited — licence , not currently licensed, last inspection rating C (2019-02-12).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CARBOPROST (CARBOPROST TROMETHAMINE)

DINProductCompanyFormStrengthStatus
02546779CARBOPROST TROMETHAMINE INJECTIONJAMP PHARMA CORPORATIONSolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed
02538377CARBOPROST TROMETHAMINE INJECTION USPJUNO PHARMA CANADA INC.SolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed
02530430CARBOPROST TROMETHAMINE INJECTION, USPDR REDDY'S LABORATORIES LTDSolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed
02230417HEMABATEPFIZER CANADA ULCSolutionCARBOPROST (CARBOPROST TROMETHAMINE) 250 MCGMarketed

Notices of Compliance

NOCDateSubmissionReason
345462024-12-11Supplement to an Abbreviated New Drug Submission (SANDS)Addition of a primary container closure system / New package labels / Update to Product Monograph / Update to package insert
Request a quote for CARBOPROST TROMETHAMINE INJECTION, USP

How to read a Canadian DIN record